UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 212

Sortiert nach

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Nature medicine, 2021-10, Vol.27 (10), p.1806-1817

2021

Volltextzugriff (PDF)

Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia

Scientific reports, 2019-03, Vol.9 (1), p.4634-4634, Article 4634

2019

Volltextzugriff (PDF)

Flowcytometric evaluation of cerebrospinal fluid in childhood ALL identifies CNS involvement better then conventional cytomorphology

Leukemia, 2021-06, Vol.35 (6), p.1773-1776

2021

Volltextzugriff (PDF)

High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia

Blood, 2012-09, Vol.120 (10), p.2064-2075

2012

Volltextzugriff (PDF)

High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia

Blood, 2010-09, Vol.116 (10), p.1747-1754

2010

Volltextzugriff (PDF)

Gene expression profiles associated with pediatric relapsed AML

PloS one, 2015-04, Vol.10 (4), p.e0121730-e0121730

2015

Volltextzugriff (PDF)

Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group

Journal of clinical oncology, 2016-08, Vol.34 (22), p.2591-2601

2016

Volltextzugriff (PDF)

Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients

Haematologica (Roma), 2017-03, Vol.102 (3), p.552

2017

Volltextzugriff (PDF)

Clinical and Prognostic Significance of Eosinophilia and Inv(16)/t(16;16) In Pediatric Acute Myelomonocytic Leukemia (AML-M4)

Blood, 2010-11, Vol.116 (21), p.1664-1664

2010

Volltextzugriff (PDF)

Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia

Cancers, 2020-05, Vol.12 (5), p.1247

2020

Volltextzugriff (PDF)

Targeting Multiple Active Kinase Pathways In 11q23 Translocated Pediatric Acute Myeloid Leukemia Using a VEGFR2 Antibody Together with a MEK Inhibitor

Blood, 2010-11, Vol.116 (21), p.3626-3626

2010

Volltextzugriff (PDF)

PTEN/AKT Pathway Mutations Are Reciprocal to NOTCH-Activating Mutations In Pediatric T-Cell Acute Lymphoblastic Lymphoma (T-ALL)

Blood, 2010-11, Vol.116 (21), p.1710-1710

2010

Volltextzugriff (PDF)

The Potential of Aurora Kinases A and B As Therapeutic Targets in Pediatric Acute Leukemia

Blood, 2012-11, Vol.120 (21), p.1465-1465

2012

Volltextzugriff (PDF)

Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups

Journal of clinical oncology, 2023-09, Vol.41 (25), p.4130

2023

Volltextzugriff (PDF)

Clinical challenges in de novo pediatric acute myeloid leukemia

Expert review of anticancer therapy, 2018-03, Vol.18 (3), p.277-293

2018

Volltextzugriff (PDF)

Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline

Journal of clinical oncology, 2019-01, Vol.37 (3), p.239-253

2019

Volltextzugriff (PDF)

Myeloid Leukemia of Down Syndrome: The Results of An International Retrospective Study

Blood, 2010-11, Vol.116 (21), p.2718-2718

2010

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2021-11, Vol.56 (11), p.2732-2741

2021

Volltextzugriff (PDF)

Efficacy and toxicity of high‐risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia

Pediatric blood & cancer, 2022-02, Vol.69 (2), p.e29387-n/a

2022

Volltextzugriff (PDF)

Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia

Leukemia, 2021-08, Vol.35 (8), p.2403-2406

2021

Volltextzugriff (PDF)

Causes of early death and treatment‐related death in newly diagnosed pediatric acute myeloid leukemia: Recent experiences of the Dutch Childhood Oncology Group

Pediatric blood & cancer, 2020-04, Vol.67 (4), p.e28099-n/a

2020

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(101)
Humans
(81)
Hematology
(64)
Child
(52)
Male
(49)
Female
(48)
Child, Preschool
(44)
Adolescent
(39)
Infant
(36)
Oncology
(33)
Pediatrics
(27)
Leukemia
(25)
Mutation
(24)
Biological And Medical Sciences
(19)
Leukemia, Myeloid, Acute - Genetics
(19)
Medical Sciences
(17)
Prognosis
(17)
Infant, Newborn
(16)
Children
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(68)
British Journal Of Haematology
(18)
Haematologica
(12)
Pediatric Blood & Cancer
(11)
Journal Of Clinical Oncology
(6)
Nature Medicine
(6)
Leukemia
(5)
Plos One
(4)
Archaea
(3)
L'orientation Scolaire Et Professionnelle
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia

Flowcytometric evaluation of cerebrospinal fluid in childhood ALL identifies CNS involvement better then conventional cytomorphology

RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML

High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia

High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia

Gene expression profiles associated with pediatric relapsed AML

Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group

Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients

Clinical and Prognostic Significance of Eosinophilia and Inv(16)/t(16;16) In Pediatric Acute Myelomonocytic Leukemia (AML-M4)

Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia

Targeting Multiple Active Kinase Pathways In 11q23 Translocated Pediatric Acute Myeloid Leukemia Using a VEGFR2 Antibody Together with a MEK Inhibitor

PTEN/AKT Pathway Mutations Are Reciprocal to NOTCH-Activating Mutations In Pediatric T-Cell Acute Lymphoblastic Lymphoma (T-ALL)

The Potential of Aurora Kinases A and B As Therapeutic Targets in Pediatric Acute Leukemia

Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups

Clinical challenges in de novo pediatric acute myeloid leukemia

Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline

Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia

Myeloid Leukemia of Down Syndrome: The Results of An International Retrospective Study

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome

Acute Lymphoblastic Leukemia in Children with Down Syndrome: A Report From the Ponte Di Legno Study Group

Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup

Efficacy and toxicity of high‐risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia

Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia

Causes of early death and treatment‐related death in newly diagnosed pediatric acute myeloid leukemia: Recent experiences of the Dutch Childhood Oncology Group

Suchergebnisse filtern